Robert Sykes

Has grant

Specialty Registrar in Cardiology and General Internal Medicine

NHS Greater Glasgow and Clyde
Country flagUnited Kingdom

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Close

Functional and structural brain abnormalities in Takotsubo syndrome

Open Date: 2025-01-01

Close Date: 2026-06-01

Grant: Close

Machine learning to simplify complex coronary small vessel diagnostics

Open Date: 2024-08-01

Close Date: 2025-08-01

Grant: Close

The StratMed-MINOCA ancillary brain health study

Open Date: 2023-01-01

Close Date: 2024-01-01

Grant: Close

Clinical associations and prognostic significance of nuclear stress test findings

Open Date: 2022-04-01

Close Date: 2023-04-01

Articles (21)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Background and Aims Angina with non-obstructive coronary arteries (ANOCA) is a prevalent myocardial ischaemic syndrome, and women are disproportionately affected. Mechanisms of ischaemia are challenging to diagnose and treatment is empirical. Methods Consecutive patients with angina (or equivalent symptoms), no angiographically severe stenosis and fractional flow reserve > 0.80 undergoing coronary functional testing were prospectively enrolled in nine centres in Europe and North America. Haemodynamic endotypes were assessed measuring coronary flow reserve and resistance using an intracoronary pressure- and temperature-sensitive sensor and bolus thermodilution. Measurements were obtained during resting conditions and following adenosine and acetylcholine. Chest pain and electrocardiographic ischaemic changes were recorded. The participant characteristics of each haemodynamic endotype were investigated using regression analysis. A three-step Delphi consensus method was applied to identify endotype-specific therapies. Results Overall, 1001 participants (mean age 62 ± 11years, 56% female) were enrolled and eight distinct endotypes were defined by adenosine testing (n = 3) and acetylcholine testing (n = 5), respectively: high resting coronary blood flow (n = 195, 19%); high resistance (n = 125, 13%); compensated high resistance (n = 112, 11%); epicardial coronary spasm (n = 162, 17%); microvascular spasm (n = 75, 8%); endothelial dysfunction (n = 96, 10%); ischaemia w/o haemodynamic changes (n = 68, 7%); and enhanced cardiac nociception (n = 79, 8%). More than one endotype occurred in 119 (12%) individuals and normal responses occurred in 234 (23%) individuals. Each endotype was associated with distinct clinical correlates. The Delphi consensus (100% ‘agree’ or ‘strongly agree’) identified endotype-specific medical therapy with a Likert scale score ≥ 6 for all endotypes. Conclusions In patients with suspected ANOCA, assessment of the symptomatic, electrocardiographic, and haemodynamic responses to adenosine and acetylcholine identifies distinct endotypes and enables mechanism-guided stratified medicine.

Year:

2026

Patients undergoing invasive coronary angiography for the investigation of chest pain commonly do not have obstructive coronary artery disease. In contemporary practice, most of these individuals do not undergo functional diagnostic tests, leaving the cause of the chest pain uncertain. Stress cardiovascular magnetic resonance imaging (MRI) can be used to measure myocardial blood flow, detect coronary microvascular dysfunction and endotype individual patients, but evidence of clinical utility from randomized trials is lacking. This study was a prospective, multicenter, parallel group, 1:1 randomized, controlled superiority trial of adenosine stress cardiovascular MRI-guided management in 250 patients (mean age, 63.3 years; 50.4% female) with chest pain and unobstructed coronary arteries. The primary outcome of the diagnostic study, defined as the reclassification of the initial diagnosis based on the angiogram, occurred in 131 patients (53.0% (95% confidence interval: 46.6−59.3%); P < 0.001), indicating that the primary outcome for the diagnostic study was met. The primary outcome of the randomized trial was the Seattle Angina Questionnaire (SAQ) summary score at 12 months after randomization. The mean ± s.d. SAQ summary scores at 12 months in the intervention and control groups were 70.9 ± 23.6 (21.7 ± 22.6 change from baseline) and 52.1 ± 24.1 (−0.8 ± 20.4 change from baseline) (adjusted mean difference: 20.9 (95% confidence interval: 15.8–26.0)), respectively, indicating that the primary outcome of the randomized trial was met. Improvements were also observed in the prespecified secondary outcome of the EQ-5D-5L questionnaire at 12 months (adjusted mean difference 0.09 (95% confidence interval: 0.04−0.13)). In this study of patients with chest pain and unobstructed coronary arteries, endotyping-informed therapy revised the diagnosis in more than half of the participants and improved angina and health-related quality of life. ClinicalTrials.gov identifier: NCT04805814 .

Year:

2026

Year:

2025

Background The relationship between atherosclerosis and endotypes of myocardial ischaemia with no obstructive coronary artery disease (INOCA) is unclear. We investigated potential associations between cumulative atherosclerotic plaque burden quantified using the Gensini score, novel invasive indices of coronary microvascular function (microvascular resistance reserve (MRR); resistive reserve ratio (RRR)) and related INOCA endotypes. Methods Coronary angiography and invasive coronary function tests were simultaneously acquired in the CorMicA cohort. A comprehensive physiological assessment was performed using both a thermodilution-based diagnostic guidewire and intracoronary acetylcholine provocation testing. Angiograms were examined for luminal stenosis in each segment of the SYNTAX coronary model. Cumulative plaque burden was quantified using the Gensini score, which incorporated both the number of diseased coronary segments and stenosis severity. Results were compared with indices of microvascular function and INOCA endotypes. Angiographic analyses were performed blind to coronary physiology findings. Results In 151 participants (median age 61 years; 73.5% female) without flow-limiting coronary artery disease, medical history included 41.7% smoking, 63.6% hypertension and 19.2% diabetes mellitus. The left anterior descending artery underwent diagnostic guidewire testing in 85.4%, and 55.0% of participants had abnormal coronary flow reserve (CFR) and/or Index of Microcirculatory Resistance (IMR). The median Gensini score was 6.0 (IQR 2.5–11.0). CFR (p=0.012), MRR (p=0.026) and RRR (p=0.026), but not IMR (p=0.445), were univariably associated with raised Gensini scores. These significant effects persisted in multivariable models controlling for potential confounders. Considering INOCA endotypes, Gensini scores differed among participants with microvascular angina (MVA) (7.0 (2.5–11.0)), vasospastic angina (VSA) (4.5 (2.0–10.0)), mixed MVA/VSA (9.0 (5.0–11.5)) and non-cardiac symptoms (3.5 (1.5–8.0)); Kruskal-Wallis p=0.030. Conclusions Reduced CFR, MRR and RRR, and MVA were associated with increased coronary atherosclerotic plaque burden, as evidenced by higher Gensini scores. These novel findings provide a mechanistic link between INOCA and cardiovascular events, reinforcing the importance of antiatherosclerosis therapy in patients with MVA.

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (19)

Jonas Persson

Karolinska Institutet

SWEDEN
View details

Jocelyn Friday

University of Glasgow

UNITED KINGDOM
View details

Jonas Spaak

Clinical Professor, Head of Research, Dept Cardiology

Karolinska Institutet

SWEDEN
View details

Nicholas Hill

Simson Professor

University of Glasgow

UNITED KINGDOM
View details

Kenneth Mangion

University of Glasgow

UNITED KINGDOM
View details

Ninian Lang

Professor of Cardiology and Cardio-Oncology

University of Glasgow

UNITED KINGDOM
View details

Alistair Church

-

UNITED KINGDOM
View details

Liam Couch

Academic Clinical Lecturer

University of Oxford

UNITED KINGDOM
View details

Patrick Mark

Professor of Nephrology

University of Glasgow

UNITED KINGDOM
View details

Paul Welsh

University of Glasgow

UNITED KINGDOM
View details

Alex McConnachie

Professor of Clinical Trial Biostatistics

University of Glasgow

UNITED KINGDOM
View details

C Berry

Personal Chair in Cardiology and Imaging

University of Glasgow

UNITED KINGDOM
View details

Olivia Wu

University of Glasgow

UNITED KINGDOM
View details

Andrew Morrow

University of Glasgow

UNITED KINGDOM
View details

Ornela Velollari

University Medical Center of the Johannes Gutenberg University Mainz

GERMANY
View details

Tamas Barany MD PhD

University of Debrecen

HUNGARY
View details

Thomas Hellmut Schindler

Professor of Medicine

Washington University in St. Louis

UNITED STATES
View details

Stuart Gray

Senior Lecturer in Exercise and Metabolic Health

University of Glasgow

UNITED KINGDOM
View details

Thomas Ford

Associate Professor

-

AUSTRALIA
View details